Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 6, 2012, Pages 501-505

  Yang, Bo ^a   Gao, Jianfei ^a   Rao, Zhiguo ^a   Shen, Qinglin ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Colorectal neoplasms; Immunohistochemistry; Matrix metalloproteinase 13; Prognosis; Survival

Indexed keywords

COLLAGENASE 3;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84866358234     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.699638     Document Type: Article

References (33)

1. Long N, Moore M A, Chen W, Gao C M, Lai M S, Mizoue T, Oyunchimeg D, Park S, Shin HR, Tajima K, Yoo KY, Sobue T. Cancer epidemiology and control in North-East Asia past, present and future. Asian Pac J Cancer Prev 2010; 11: 107-48.
2. Parkin DM, Bray F, Ferlay J, Pisani P. G lobal cancer statistics . CA Cancer J Clin 2005; 55: 74-108.
3. Luukkaa H, Klemi P, Leivo I, Mäk itie A A, Irish J, Gilbert R, Perez-Ordonez B, Hirsim ä ki P, Vahlberg T, Kivisaari A, Kä h ä ri VM, Gr é nman R. Expression of matrix metalloproteinases-1,-7,-9,-13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer. Head Neck 2010; 32: 1019-27.
4. Klinge U, Rosch R, Junge K, Krones C J, Stumpf M, Lynen-Jansen P, Mertens PR, Schumpelick V. Different matrix micro-environments in colon cancer and diverticular disease . Int J Colorectal Dis 2007; 22: 515-20.
5. Mak I W, Turcotte R E, Popovic S, Singh G, Ghert M. A P-1 as a regulator of MMP-13 in the stromal cell of giant cell tumor of bone. Biochem Res Int 2011; 2011: 164197.
6. Yongming Li, Lin T ang, Yinzhong Duan, Yin Ding. U pregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells. BMC Res Notes 2010; 3: 309-16.
7. Gordana Konjevi, Sandra Stankovi. M atrix metalloproteinases in the process of invasion and metastasis of breast cancer. Arch Oncol 2006; 14: 136-40.
8. Deryugina EI, Quigley JP. M atrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-10.
9. Lemaitre V, D 'A rmiento J. M atrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78: 1-10.
10. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-50.
11. Deng SJ, Bickett DM, Mitchell JL, Lambert MH, Blackburn RK, Carter HL, Neugebauer J, Pahel G, Weiner MP, Moss ML. Substrate specifi city of human collagenase 3 assessed using a phage-displayed peptide library. J Biol Chem 2000; 275: 31422-27.
12. Tardif G, Reboul P, Pelletier JP, Martel-Pelletier J. T en years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol 2004; 14: 197-204.
13. Davis N C, Evans E B, Cohen J R, Theile D E. S taging of colorectal cancer, the Australian clinico-pathological staging (ACPS) system compared with Dukes ' system. Dis Colon Rectum 1984; 27: 707-13.
14. O-Charoenrat P, Rhys-Evans PH, Eccles SA. E xpression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001; 127: 813-20.
15. Brinckerhoff CE, Matrisian LM. M atrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002; 3: 207-14.
16. Sternlicht MD, Werb Z. H ow matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
17. Lafl eur MA, Handsley MM, Edwards DR. M etalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 2003; 5: 1-39.
18. Ala-aho R, Ahonen M, George S J, Heikkil ä J, Gr é nman R, Kallajoki M, Kä h ä ri VM. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene 2004; 23: 5111-23.
19. Lafl eur MA, Drew AF, de Sousa EL, Blick T, Bills M, Walker EC, Williams ED, Waltham M, Thompson EW. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer 2005; 114: 544-54.
20. Culhaci N, Metin K, Copcu E, Dikicioglu E. E levated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may refl ect increased tumor invasiveness . BMC Cancer 2004; 4: 42.
21. Curran S, Murray GI. M atrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-30.
22. Itoh Y, Nagase H. M atrix metalloproteinases in cancer. Essays Biochem 2002; 38: 21-36.
23. Yu AE, Hewitt R E, Connor E W, Stetler W G. M atrix metalloproteinases, novel targets for directed cancer therapy. Drugs Aging 1997; 11: 229-44.
24. Lynch CC, Matrisian LM. M atrix metalloproteinases in tumor-host cell communication. Differentiation 2002; 70: 561-73.
25. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 2008; 8: 83-92.
26. Pei Y, Harvey A, Yu X P, Chandrasekhar S, Thirunavukkarasu K. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis Cartilage 2006; 14: 749-58.
27. Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep 2009; 22: 1119-27.
28. Hellman NE, Spector J, Robinson J, Zuo X, Saunier S, Antignac C, Tobias JW, Lipschutz JH. Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J Biol Chem 2008; 283: 4272-82.
29. Lederle W, Hartenstein B, Meides A, Kunzelmann H, Werb Z, Angel P. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 2010; 31: 1175-84.
30. Curran S, Dundas S R, Buxton J, Leeman M F, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifi es poor prognosis colorectal cancers. Clin Cancer Res 2004; 10: 8229-34.
31. Leeman M F, McKay J A, Murray G I. M atrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002; 55: 758-62.
32. Leeman MF, Curran S, Murray GI. T he structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 2002; 37: 149-66.
33. Lyall MS, Dundas SR, Curran S, Murray GI. P rofi ling markers of prognosis in colorectal cancer. Clin Cancer Res 2006; 12: 1184-91.